Healthcare - Biotechnology - NASDAQ - US
$ 26.63
-5.06 %
$ 3.91 B
Market Cap
-12.05
P/E
Price Target
Average
89.26%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
14.87%
Net Income
Estimate
23.84%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Immunovant, Inc.
Wall Street analysts predict an average 1-year price target for IMVT of $50.4 , with forecasts ranging from a low of $46 to a high of $57 .
IMVT Lowest Price Target
Wall Street Target
46 USD
72.74%
IMVT Average Price Target
Wall Street Target
50.4 USD
89.26%
IMVT Highest Price Target
Wall Street Target
57 USD
114.04%
REVENUE FORECAST
Revenue Forecast Chart IMVT
EBIT FORECAST
EBIT Forecast Chart IMVT
NET INCOME FORECAST
Net Income Chart IMVT